EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,400,000 | -56.4% | 3,673,443 | -65.9% | 0.00% | – |
Q1 2022 | $12,394,000 | -34.9% | 10,778,038 | +41.5% | 0.00% | – |
Q4 2021 | $19,040,000 | -50.7% | 7,615,648 | +0.9% | 0.00% | -100.0% |
Q3 2021 | $38,627,000 | -40.7% | 7,544,359 | -3.7% | 0.00% | -50.0% |
Q2 2021 | $65,084,000 | -11.0% | 7,832,020 | -6.7% | 0.00% | 0.0% |
Q1 2021 | $73,094,000 | -14.9% | 8,392,058 | +6.1% | 0.00% | -33.3% |
Q4 2020 | $85,914,000 | -6.1% | 7,911,028 | +3.1% | 0.00% | 0.0% |
Q3 2020 | $91,529,000 | -25.0% | 7,672,267 | +1.0% | 0.00% | -40.0% |
Q2 2020 | $121,996,000 | +15.2% | 7,596,285 | +11.3% | 0.01% | 0.0% |
Q1 2020 | $105,873,000 | -37.9% | 6,826,045 | -1.5% | 0.01% | -28.6% |
Q4 2019 | $170,471,000 | +142.7% | 6,929,696 | +1.7% | 0.01% | +133.3% |
Q3 2019 | $70,248,000 | -13.1% | 6,810,520 | +5.7% | 0.00% | 0.0% |
Q2 2019 | $80,831,000 | +33.5% | 6,440,597 | +31.8% | 0.00% | 0.0% |
Q1 2019 | $60,566,000 | +89.3% | 4,888,381 | -5.9% | 0.00% | +50.0% |
Q4 2018 | $31,990,000 | -30.8% | 5,193,287 | +19.0% | 0.00% | 0.0% |
Q3 2018 | $46,242,000 | -20.7% | 4,362,472 | +1.4% | 0.00% | -33.3% |
Q2 2018 | $58,315,000 | -15.7% | 4,303,720 | +10.4% | 0.00% | 0.0% |
Q1 2018 | $69,174,000 | +39.0% | 3,897,179 | -1.7% | 0.00% | +50.0% |
Q4 2017 | $49,766,000 | -22.8% | 3,965,391 | +17.1% | 0.00% | -33.3% |
Q3 2017 | $64,497,000 | +29.9% | 3,385,729 | +3.0% | 0.00% | 0.0% |
Q2 2017 | $49,636,000 | -10.1% | 3,287,097 | +2.1% | 0.00% | 0.0% |
Q1 2017 | $55,198,000 | +100260.0% | 3,218,631 | +70561.5% | 0.00% | – |
Q4 2016 | $55,000 | +22.2% | 4,555 | -0.2% | 0.00% | – |
Q3 2016 | $45,000 | 0.0% | 4,563 | +5.1% | 0.00% | – |
Q2 2016 | $45,000 | +18.4% | 4,343 | +38.8% | 0.00% | – |
Q1 2016 | $38,000 | +245.5% | 3,129 | +373.4% | 0.00% | – |
Q4 2015 | $11,000 | 0.0% | 661 | -23.1% | 0.00% | – |
Q3 2015 | $11,000 | -38.9% | 859 | +16.1% | 0.00% | – |
Q2 2015 | $18,000 | +200.0% | 740 | +151.7% | 0.00% | – |
Q1 2015 | $6,000 | 0.0% | 294 | 0.0% | 0.00% | – |
Q4 2014 | $6,000 | -25.0% | 294 | 0.0% | 0.00% | – |
Q3 2014 | $8,000 | -11.1% | 294 | 0.0% | 0.00% | – |
Q2 2014 | $9,000 | +125.0% | 294 | +50.8% | 0.00% | – |
Q1 2014 | $4,000 | +33.3% | 195 | +47.7% | 0.00% | – |
Q4 2013 | $3,000 | -40.0% | 132 | 0.0% | 0.00% | – |
Q3 2013 | $5,000 | – | 132 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |